Search Results - "Delforge M"

Diverse roles of YTHDC1 in chromatin and blood cancers.

Authors: Pernon B Benchikh Y Fournier C et al.

Source: Frontiers in genetics [Front Genet] 2026 May 08; Vol. 17, pp. 1773468. Date of Electronic Publication: 2026 May 08 (Print Publication: 2026).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101560621 Publication Model: eCollection Cited Medium: Print ISSN: 1664-8021 (Print) Linking ISSN: 16648021 NLM ISO Abbreviation: Front Genet Subsets: PubMed not MEDLINE

Author Index.

Source: HIV Medicine. Dec2023 Supplement 1, Vol. 24, p789-818. 30p.

Combined Immune Checkpoint Inhibitors and Radiation Therapy in Patients with Multiple Myeloma and Extramedullary Medullary Disease: A Real-World Retrospective Analysis.

Authors: Zhang, Lili Bangolo, Ayrton Amoozgar, Behzad et al.

Source: Cancers. Jun2026, Vol. 18 Issue 12, p1996. 13p.

A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment—USMIRC Group.

Authors: Hameed, Maha Habib, Alma Khan, Abdullah Mohammad et al.

Source: Cancers. Mar2026, Vol. 18 Issue 5, p740. 12p.

A Phase II Study of Daratumumab in Combination with Bortezomib and Dexamethasone in Patients with Multiple Myeloma Who Received One Prior Line of Therapy (KMM1906).

Authors: Yoo, Kwai Han Yoon, Sang Eun Kang, Ka-Won et al.

Source: Cancer Research & Treatment. Jul2026, Vol. 58 Issue 3, p963-970. 8p.

Evaluation of Real-World Studies on Management of Relapsed Multiple Myeloma After BCMA-Directed Therapy Failure from U.S. Academic Centers and USMIRC.

Authors: Youssef, Nagham Hameed, Maha Atrash, Shebli et al.

Source: Current Oncology. Jun2026, Vol. 33 Issue 6, p355. 16p.

Sociodemographic, Clinical, and Therapeutic Characterization of Multiple Myeloma Patients (CharisMMa Study) with Symptomatic Relapse and/or Refractory Disease: An Observational, Multicenter Study in Portugal.

Authors: Bergantim, Rui Freitas, José Guilherme Gonçalves, Cristina et al.

Source: Hematology Reports. Jun2026, Vol. 18 Issue 3, p34. 15p.

Author Index.

Source: HIV Medicine. Oct2021 Supplement S1, Vol. 22, p310-327. 18p.

Multidisciplinary approach to managing GPRC5D-related adverse events in relapsed or refractory multiple myeloma patients.

Authors: Albrecht N Boeckx E Caers J et al.

Source: Annals of hematology [Ann Hematol] 2026 Jul 16. Date of Electronic Publication: 2026 Jul 16.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

Immunophenotypic changes in the tumor and tumor microenvironment during progression to multiple myeloma.

Authors: Bergiers I Köse MC Skerget S et al.

Source: PLoS genetics [PLoS Genet] 2025 Oct 07; Vol. 21 (10), pp. e1011848. Date of Electronic Publication: 2025 Oct 07 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101239074 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7404 (Electronic) Linking ISSN: 15537390 NLM ISO Abbreviation: PLoS Genet Subsets: MEDLINE

Antibody-Drug Conjugates, T-Cell Engager Bispecific Antibodies and Chimeric Antigen Receptor T Cells for Multiple Myeloma: What's the Current Status?

Authors: Segers F Delforge M

Source: Targeted oncology [Target Oncol] 2026 Jan; Vol. 21 (1), pp. 63-86. Date of Electronic Publication: 2026 Jan 21.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

Graphene-Based 3D Scaffolds in Bone Regeneration: Emerging Opportunities for MRONJ Treatment.

Authors: Catalano, Claudio Gerini, Giulia Podda, Gian Marco et al.

Source: Pharmaceutics. Mar2026, Vol. 18 Issue 3, p335. 33p.

Acquired von Willebrand syndrome secondary to monoclonal gammopathy: a single-center case series.

Authors: Van Thillo Q Segers F Brijs J et al.

Source: Therapeutic advances in hematology [Ther Adv Hematol] 2025 Jun 24; Vol. 16, pp. 20406207251347235. Date of Electronic Publication: 2025 Jun 24 (Print Publication: 2025).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101549589 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6207 (Print) Linking ISSN: 20406207 NLM ISO Abbreviation: Ther Adv Hematol Subsets: PubMed not MEDLINE

Author index.

Source: Fundamental & Clinical Pharmacology. Apr2016 Supplement, Vol. 30, p89-98. 10p.

EACS 2019 – Author Index.

Source: HIV Medicine. Nov2019 Supplement S9, Vol. 20, p317-337. 21p.

The novel family of Warbicin^® compounds inhibits glucose uptake both in yeast and human cells and restrains cancer cell proliferation.

Authors: Vanthienen W Fernández-García J Baietti MF et al.

Source: Frontiers in oncology [Front Oncol] 2024 Aug 22; Vol. 14, pp. 1411983. Date of Electronic Publication: 2024 Aug 22 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Cardiovascular Magnetic Resonance Elastography: Current Evidence, Challenges, and Future Perspectives.

Authors: Wollandt, Alexander Gruenewald, Leon D. Booz, Christian et al.

Source: Diagnostics (2075-4418). Jul2026, Vol. 16 Issue 14, p2233. 26p.

A Bioequivalence Study Comparing Two Pomalidomide Hard Capsule Formulations in Healthy Chilean Subjects.

Authors: Davanço, Marcelo Gomes Vespasiano, Thaís Pereira Moisan, Jessé et al.

Source: Pharmaceuticals (14248247). Jul2026, Vol. 19 Issue 7, p1089. 16p.

Low-Frequency PPM1D Gene Mutations Affect Treatment Response to BCMA-Targeted CAR T-Cell Therapy in Multiple Myeloma.

Authors: van der Weg, Katharina Bertschinger, Martina Bacher, Ulrike et al.

Source: Cancers. Jul2026, Vol. 18 Issue 13, p2032. 13p.

Quality of Life in CAR-T Cell Therapy.

Authors: Alati, Caterina Pitea, Martina Porto, Gaetana et al.

Source: Hematology Reports. Jun2026, Vol. 18 Issue 3, p40. 25p.